Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables Refunds
Ratios

Immunocore Holdings (IMCR) Accumulated Depreciation & Amortization (2022 - 2025)

Immunocore Holdings' Accumulated Depreciation & Amortization history spans 4 years, with the latest figure at $3.1 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 26.19% year-over-year to $3.1 million; the TTM value through Dec 2025 reached $3.1 million, down 26.19%, while the annual FY2025 figure was $3.1 million, 26.19% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $3.1 million at Immunocore Holdings, down from $4.2 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $5.3 million in Q4 2022 and bottomed at $3.1 million in Q4 2025.
  • The 4-year median for Accumulated Depreciation & Amortization is $4.1 million (2024), against an average of $4.2 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization increased 2.44% in 2024 before it dropped 26.19% in 2025.
  • A 4-year view of Accumulated Depreciation & Amortization shows it stood at $5.3 million in 2022, then fell by 22.64% to $4.1 million in 2023, then increased by 2.44% to $4.2 million in 2024, then dropped by 26.19% to $3.1 million in 2025.
  • Per Business Quant, the three most recent readings for IMCR's Accumulated Depreciation & Amortization are $3.1 million (Q4 2025), $4.2 million (Q4 2024), and $4.1 million (Q4 2023).